FindTrial
Sign In

EBUS-TBNA Diagnostic Yield and Complication in Patients Mediastinal Lymphadenopathy; Clinicorardiological and Pathological/microbiological Correlation

Diagnostic Yield and Complications of Endobronchial Ultrasound-Transbronchial Needle Aspiration (EBUS-TBNA) in Patients with Mediastinal Lymphadenopathy with Clinico-Radiological and Cyto/Histo -Pathological/ Microbiological Correlation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/04/051816
Enrollment
100
Registered
2023-04-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J99- Respiratory disorders in diseasesclassified elsewhere

Interventions

None listed

Sponsors

Department of Pulmonary Medicine, SCB-MCH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Mediastinal Lymphadenopathy

Exclusion criteria

Exclusion criteria: Patient Bleeding diathesis Patient with refractory hypoxia Hemodynamically unstable patient Chronic renal disease HIV, HCV, HBsAg positive patients Active smear positive tuberculosis patient COVID-19 positive patients Nonconsenting patient History of recent acute coronary syndrome

Design outcomes

Primary

MeasureTime frame
Estimation of diagnostic yield and complication rate of EBUS-TBNA. Timepoint: 24 weeks—

Secondary

MeasureTime frame
Estimation of diagnostic yield and complication rate of EBUS-TBNA.Timepoint: 24 weeks—

Countries

India

Contacts

Public ContactOnkar Kumar Jha

SCB Medical College and Hospital

manoranjanm2015@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026